The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines
Open accessAbstract
Significance: The COVID-19 pandemic caused by SARS-CoV-2 infection has led to more than 840,000 deaths worldwide as of August 31, 2020. Unfortunately, no licensed vaccine or specific treatment is available right now. Herein, we report a decoy nanoparticle against COVID-19. The decoy nanoparticles were constructed by fusing cell membrane nanovesicles derived from genetically engineered cells, which stably express SARS-CoV-2 receptor ACE2, and human monocytes, which display abundant cytokine receptors. By competing with host cells, these nanodecoys efficiently adsorb viruses and inflammatory cytokines such as IL-6 and GM-CSF. These two functionalities allow effective intervention of viral infection and its associated immune disorder, presenting a promising therapeutic strategy for COVID-19 and other potential epidemics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Self-citationA pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Toxic potential of materials at the nanolevel
Nel, A., Xia, T., Mädler, L., & Li, N. (2006) · Science · doi:10.1126/science.1114397 · Cited by 9,324
A novel coronavirus outbreak of global health concern
Wang, C., Horby, P. W., Hayden, F. G., & Gao, G. F. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30185-9 · Cited by 7,700
Wang, Y., Zhang, D., Du, G., Du, R., Zhao, J., Jin, Y., Fu, S., Gao, L., Cheng, Z., Lu, Q., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31022-9 · Cited by 3,440
Effective treatment of severe COVID-19 patients with tocilizumab
Xu, X., Han, M., Li, T., Sun, W., Wang, D., Fu, B., Zhou, Y., Zheng, X., Yang, Y., Li, X., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2005615117 · Cited by 2,647
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Merad, M., & Martin, J. C. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0331-4 · Cited by 2,472
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
Hu, C.-M. J., Zhang, L., Aryal, S., Cheung, C., Fang, R. H., & Zhang, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106634108 · Cited by 2,433
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review
Sanders, J. M., Monogue, M. L., Jodlowski, T. Z., & Cutrell, J. B. (2020) · JAMA · doi:10.1001/jama.2020.6019 · Cited by 2,347
Cytokine release syndrome in severe COVID-19
Moore, J. B., & June, C. H. (2020) · Science · doi:10.1126/science.abb8925 · Cited by 1,912
COVID-19: immunopathology and its implications for therapy
Cao, X. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0308-3 · Cited by 1,609
Xia, S., Liu, M., Wang, C., Xu, W., Lan, Q., Feng, S., Qi, F., Bao, L., Du, L., Liu, S., et al. (2020) · Cell Research · doi:10.1038/s41422-020-0305-x · Cited by 1,343
Self-citationPathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients
Zhou, Y., Fu, B., Zheng, X., Wang, D., Zhao, C., Qi, Y., Sun, R., Tian, Z., Xu, X., & Wei, H. (2020) · National Science Review · doi:10.1093/nsr/nwaa041 · Cited by 1,295
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
Bao, L., Deng, W., Huang, B., Gao, H., Liu, J., Ren, L., Wei, Q., Yu, P., Xu, Y., Qi, F., et al. (2020) · Nature · doi:10.1038/s41586-020-2312-y · Cited by 1,126
Self-citationZhang, Q., Dehaini, D., Zhang, Y., Zhou, J., Chen, X., Zhang, L., Fang, R. H., Gao, W., & Zhang, L. (2018) · Nature Nanotechnology · doi:10.1038/s41565-018-0254-4 · Cited by 958
Self-citationModified mRNA vaccines protect against zika virus infection
Richner, J. M., Himansu, S., Dowd, K. A., Butler, S. L., Salazar, V., Fox, J. M., Julander, J. G., Tang, W. W., Shresta, S., Pierson, T. C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.017 · Cited by 909
A biomimetic nanosponge that absorbs pore-forming toxins
Hu, C.-M. J., Fang, R. H., Copp, J., Luk, B. T., & Zhang, L. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.54 · Cited by 751
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
Xia, S., Zhu, Y., Liu, M., Lan, Q., Xu, W., Wu, Y., Ying, T., Liu, S., Shi, Z., Jiang, S., et al. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0374-2 · Cited by 704
Self-citationClinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
Williamson, B. N., Feldmann, F., Schwarz, B., Meade-White, K., Porter, D. P., Schulz, J., van Doremalen, N., Leighton, I., Yinda, C. K., Pérez-Pérez, L., et al. (2020) · Nature · doi:10.1038/s41586-020-2423-5 · Cited by 689
Translating IL-6 biology into effective treatments
Choy, E. H., De Benedetti, F., Takeuchi, T., Hashizume, M., John, M. R., & Kishimoto, T. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0419-z · Cited by 668
Thamphiwatana, S., Angsantikul, P., Escajadillo, T., Zhang, Q., Olson, J., Luk, B. T., Zhang, S., Fang, R. H., Gao, W., Nizet, V., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714267114 · Cited by 563
Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism
Cagno, V., Andreozzi, P., D’Alicarnasso, M., Jacob Silva, P., Mueller, M., Galloux, M., Le Goffic, R., Jones, S. T., Vallino, M., Hodek, J., et al. (2018) · Nature Materials · doi:10.1038/nmat5053 · Cited by 428
Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity
Zhang, Q., Honko, A., Zhou, J., Gong, H., Downs, S. N., Vasquez, J. H., Fang, R. H., Gao, W., Griffiths, A., & Zhang, L. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c02278 · Cited by 346
A distinct name is needed for the new coronavirus
Jiang, S., Shi, Z., Shu, Y., Song, J., Gao, G. F., Tan, W., & Guo, D. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30419-0 · Cited by 329
Self-citationPulmonary surfactant–biomimetic nanoparticles potentiate heterosubtypic influenza immunity
Wang, J., Li, P., Yu, Y., Fu, Y., Jiang, H., Lu, M., Sun, Z., Jiang, S., Lu, L., & Wu, M. X. (2020) · Science · doi:10.1126/science.aau0810 · Cited by 306
Self-citationChu, D., Gao, J., & Wang, Z. (2015) · ACS Nano · doi:10.1021/acsnano.5b05583 · Cited by 283
Decoy exosomes provide protection against bacterial toxins
Keller, M. D., Ching, K. L., Liang, F.-X., Dhabaria, A., Tam, K., Ueberheide, B. M., Unutmaz, D., Torres, V. J., & Cadwell, K. (2020) · Nature · doi:10.1038/s41586-020-2066-6 · Cited by 238
Henry, B. D., Neill, D. R., Becker, K. A., Gore, S., Bricio-Moreno, L., Ziobro, R., Edwards, M. J., Mühlemann, K., Steinmann, J., Kleuser, B., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3037 · Cited by 233
Rao, L., Meng, Q., Huang, Q., Wang, Z., Yu, G., Li, A., Ma, W., Zhang, N., Guo, S., Zhao, X., et al. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201803531 · Cited by 226
Self-citationGM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches
Lang, F. M., Lee, K. M.-C., Teijaro, J. R., Becher, B., & Hamilton, J. A. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0357-7 · Cited by 221
Genetically Engineered Liposome‐like Nanovesicles as Active Targeted Transport Platform
Zhang, P., Zhang, L., Qin, Z., Hua, S., Guo, Z., Chu, C., Lin, H., Zhang, Y., Li, W., Zhang, X., et al. (2018) · Advanced Materials · doi:10.1002/adma.201705350 · Cited by 201
Self-citationHirotani, T., Lee, P. Y., Kuwata, H., Yamamoto, M., Matsumoto, M., Kawase, I., Akira, S., & Takeda, K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3650 · Cited by 167
Virus-mimetic nanovesicles as a versatile antigen-delivery system
Zhang, P., Chen, Y., Zeng, Y., Shen, C., Li, R., Guo, Z., Li, S., Zheng, Q., Chu, C., Wang, Z., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505799112 · Cited by 149
Self-citationCell-Membrane-Mimicking Nanodecoys against Infectious Diseases
Rao, L., Tian, R., & Chen, X. S. (2020) · ACS Nano · doi:10.1021/acsnano.0c01665 · Cited by 143
Self-citationBanerjee, A., Nasir, J. A., Budylowski, P., Yip, L., Aftanas, P., Christie, N., Ghalami, A., Baid, K., Raphenya, A. R., Hirota, J. A., et al. (2020) · Emerging infectious diseases · doi:10.3201/eid2609.201495 · Cited by 134
Therapeutic treatment of Zika virus infection using a brain-penetrating antiviral peptide
Jackman, J. A., Costa, V. V., Park, S.-H., Real, A. L. C. V., Park, J. H., Cardozo, P. L., Ferhan, A. R., Olmo, I. G., Moreira, T. P., Bambirra, J. L., et al. (2018) · Nature Materials · doi:10.1038/s41563-018-0194-2 · Cited by 108
Rao, L., Wang, W., Meng, Q., Tian, M., Cai, B., Wang, Y., Li, A., Zan, M., Xiao, F., Bu, L., et al. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b03913 · Cited by 83
Self-citationHe, Y., Li, J., Du, L., Yan, X., Hu, G., Zhou, Y., & Jiang, S. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.04.054 · Cited by 62
Self-citation
Cited by
Recent applications of immunomodulatory biomaterials for disease immunotherapy
Dai, H., Fan, Q., & Wang, C. (2022) · Exploration · doi:10.1002/exp.20210157 · Cited by 268
Wang, Z., Popowski, K. D., Zhu, D., de Juan Abad, B. L., Wang, X., Liu, M., Lutz, H., De Naeyer, N., DeMarco, C. T., Denny, T. N., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00902-5 · Cited by 264
Cui, Y., Lv, B., Li, Z., Ma, C., Gui, Z., Geng, Y., Liu, G., Sang, L., Xu, C., Min, Q., et al. (2024) · Small · doi:10.1002/smll.202303494 · Cited by 81
Yang, K.-C., Lin, J.-C., Tsai, H.-H., Hsu, C.-Y., Shih, V., & Hu, C.-M. J. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00965-y · Cited by 39
“demonstrated that ACE2-displaying membrane vesicles could be derived from genetically engineered 293 T cells, which provide a more readily available source for the membrane vesicle [139].”
Background
Metadata
- Authors
- Rao, L., Xia, S., Xu, W., Tian, R., Yu, G., Gu, C., Pan, P., Meng, Q.-F., Cai, X., Qu, D., Lu, L., Xie, Y., Jiang, S., & Chen, X.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2020-10-06
- Volume
- 117
- Issue
- 44
- Pages
- 27141-27147
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W3092644167
- Cited by
- 260
- References
- 40
- FWCI
- 5.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.